Chlorpropamide (Compound)

Synonyms:chlorpropamide, 94-20-2, Chloropropamide, Diabinese, Glucamide, Meldian, Chlorpropamid, Diabenese, Chlorodiabina, Chloronase, Diabeneza, Diabetoral, Adiaben, Catanil, Diabaril, Dynalase, Insulase, Melitase, Diabechlor, Diabenal, Mellinese, Millinese, Asucrol, Glisema, Oradian, Diabet-Pages, Diamel Ex, 1-(4-Chlorophenylsulfonyl)-3-propylurea, Clorpropamide, Diabexan, Prodiaben, 4-chloro-N-(propylcarbamoyl)benzenesulfonamide, Chlorpropamidum, Clorpropamida, 1-(p-Chlorobenzenesulfonyl)-3-propylurea, 1-(4-chlorophenyl)sulfonyl-3-propylurea, 1-Propyl-3-(p-chlorobenzenesulfonyl)urea, N-(4-Chlorophenylsulfonyl)-N'-propylurea, N-(p-Chlorobenzenesulfonyl)-N'-propylurea, N-Propyl-N'-(p-chlorobenzenesulfonyl)urea, 4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide, 1-(p-Chlorophenylsulfonyl)-3-propylurea, 1-p-Chlorophenyl-3-(propylsulfonyl)urea, NCI-C01752, 4-Chloro-N-((propylamino)carbonyl)benzenesulfonamide, N-Propyl-N'-p-chlorphenylsulfonylcarbamide, 1-((p-Chlorophenyl)sulfonyl)-3-propylurea, n-Propyl-N'-p-chlorophenylsulfonylcarbamide, 1-[(4-chlorobenzene)sulfonyl]-3-propylurea, P 607, NSC 44634, Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-, U-9818, 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide, Benzenesulfonamide, 4-chloro-N-[(propylamino)carbonyl]-, Clorpropamid, MFCD00079004, NSC-44634, WTM2C3IL2X, CHEMBL498, NSC-626720, 1-(4-chlorobenzenesulfonyl)-3-propylurea, MLS000028395, CHEBI:3650, Bioglumin, DTXSID9020322, Insogen, Urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-, NSC626720, CAS-94-20-2, NCGC00015216-11, Chlorporpamide, SMR000058364, Clorpropamide [DCIT], chlorpropamide, alpha-form, Clorpropamide [Italian], Urea, 1-[(p-chlorophenyl)sulfonyl]-3-propyl-, chlorpropamide, epsilon-form, chlorpropamide, epsilon`-form, DTXCID30322, Chlorpropamidum [INN-Latin], Clorpropamida [INN-Spanish], Diabinese (TN), CCRIS 155, 1-(p-Chlorobenzensulfonyl)-3-propylurea, HSDB 2051, 4-chloro-n-(propylaminocarbonyl)benzenesulfonamide, SR-01000000060, 4-chloro-N-((propylaminocarbonyl)benzenesulfonamide, EINECS 202-314-5, UNII-WTM2C3IL2X, U-3818, NSC 626720, BRN 2218363, Urea, 1-((p-chloropenyl)sulfonyl)-3-propyl-, Prestwick_684, Chlorpropamide [USP:INN:BAN:JAN], Chlorpropamide B.P., Chlorpropamide-[d4], Spectrum_000144, 1-(4-chlorophenyl)sulfonyl-3-propyl-urea, Opera_ID_359, ADENYLOSUCCINICACID, Prestwick0_000323, Prestwick1_000323, Prestwick2_000323, Prestwick3_000323, Spectrum2_000089, Spectrum3_000347, Spectrum4_000284, Spectrum5_000719, WLN: GR DSWMVM3, Lopac-C-1290, chlorpropamide, delta-form, 1-(4-chloro-benzenesulfonyl)-3-n-propyl-urea, C 1290, CHLORPROPAMIDE [MI], CHLORPROPAMIDE [INN], CHLORPROPAMIDE [JAN], Lopac0_000229, SCHEMBL23947, BSPBio_000325, BSPBio_002013, CHLORPROPAMIDE [HSDB], KBioGR_000808, KBioGR_002273, KBioSS_000624, KBioSS_002274, MLS001148665, CHLORPROPAMIDE [VANDF], DivK1c_000513, SPECTRUM1500185, SPBio_000018, SPBio_002246, CHLORPROPAMIDE [MART.], BPBio1_000359, GTPL6801, CHLORPROPAMIDE [USP-RS], CHLORPROPAMIDE [WHO-DD], HMS501J15, KBio1_000513, KBio2_000624, KBio2_002273, KBio2_003192, KBio2_004841, KBio2_005760, KBio2_007409, KBio3_001233, KBio3_002753, Chlorpropamide (JP17/USP/INN), cMAP_000007, NINDS_000513, HMS1569A07, HMS1920M05, HMS2091E08, HMS2096A07, HMS2233L19, HMS3259A17, HMS3260N19, HMS3373D09, HMS3428C03, HMS3652L03, HMS3713A07, Pharmakon1600-01500185, BCP09162, HY-B1429, NSC44634, CHLORPROPAMIDE [EP IMPURITY], CHLORPROPAMIDE [ORANGE BOOK], Tox21_110102, Tox21_201391, Tox21_302789, Tox21_500229, AC8695, BDBM50344965, CCG-38905, NSC756690, NSC813219, s4166, STK857458, CHLORPROPAMIDE [USP MONOGRAPH], AKOS001482739, Tox21_110102_1, CS-4917, DB00672, KS-5316, LP00229, NC00503, NSC-756690, NSC-813219, SDCCGSBI-0050217.P005, IDI1_000513, MRF-0000539, NCGC00015216-01, NCGC00015216-02, NCGC00015216-03, NCGC00015216-04, NCGC00015216-05, NCGC00015216-06, NCGC00015216-07, NCGC00015216-08, NCGC00015216-09, NCGC00015216-10, NCGC00015216-12, NCGC00015216-13, NCGC00015216-14, NCGC00015216-17, NCGC00015216-18, NCGC00015216-23, NCGC00021451-03, NCGC00021451-04, NCGC00021451-05, NCGC00021451-06, NCGC00021451-07, NCGC00021451-08, NCGC00256414-01, NCGC00258942-01, NCGC00260914-01, SY052508, SBI-0050217.P004, AB00051944, C1220, Chlorpropamide, analytical standard, >=97%, EU-0100229, P-607, SW196839-3, A16447, D00271, Urea, 1-propyl-3-(p-chloro-benzenesulfonyl)-, AB00051944_16, AB00051944_17, EN300-7388134, Q1075324, SR-01000000060-2, SR-01000000060-4, SR-01000000060-6, W-100205, 4-Chloro-N-[(propylamino)-carbonyl]benzenesulfonamide, BRD-K97746869-001-05-6, BRD-K97746869-001-15-5, Z276509110, 1-Chloro-4-(([(propylamino)carbonyl]amino)sulfonyl)benzene #, Chlorpropamide, European Pharmacopoeia (EP) Reference Standard, Chlorpropamide, United States Pharmacopeia (USP) Reference Standard, Chlorpropamide, Pharmaceutical Secondary Standard; Certified Reference Material
Pubchem:PUBCHEM:2727
Id:718c7971-e9ca-5267-9d6c-7d27d819ca2e
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Chlorpropamide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Chlorpropamide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Chlorpropamide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.